Best Biotech Stocks Right Now: Growth Leaders to Watch
Biotech stocks rally as late-stage trial data and regulatory milestones boost investor confidence. Analysts say the b...
When index levels fall, use a calm, systematic approach to reassess risk, rebalance as needed, and protect capital. This intro covers the core steps you can take now.
13,497 articlesBiotech stocks rally as late-stage trial data and regulatory milestones boost investor confidence. Analysts say the b...
Starting late is common. This beginner's guide to retirement accounts breaks down 401(k)s, IRAs, and HSAs, plus a sim...
A sharp reversal in momentum stock leaders has sparked a broader market rotation. Traders weigh what comes next as vo...
As investors await a potential new federal reserve chair, analysts say the policy path could lift small-cap stocks. T...
New SPIVA data shows 9 in 10 active large-cap funds underperform the S&P 500 over 15 years, a reality that challenges...
May surprised many investors with broad gains across major asset classes. This guide breaks down who led, why, and pr...
May CPI rose 0.5% from April, lifting the annual rate to 4.2%. Energy drove most of the move, while core inflation st...
Two popular ETFs battle for a place in income-focused portfolios: Fidelity's FNCL versus iShares IAT. This guide brea...
The MBA reports a 1.0% weekly rise in mortgage applications, driven by refinancing activity as rates paused near 6.6%...
A new MLP income ETF employs a covered call overlay to lift yield beyond AMLP, drawing attention from income-focused ...
Retirees are shifting from Florida's sun-soaked appeal to states with lower taxes, cheaper housing, and fewer hurrica...
A historic $8.3 billion signal from institutional investors just sent a warning about market risk. Learn what it sign...